July 30, 2012

CONRAD Announces New Leadership


Beginning August 1st, Henry L. Gabelnick, PhD, will transition from his long-time role as Executive Director of CONRAD to assume the role of Senior Advisor and bring his deep expertise in the areas of reproductive health and HIV prevention to ongoing and special projects.  Associate Director and Chief Scientific Officer Gustavo Doncel, MD, PhD will take over as Executive Director at that time. 

Dr. Gabelnick was one of the first staff members of CONRAD when it was established in 1986 and has been responsible for bringing more than $400 million to the program.  In addition, Dr. Gabelnick has overseen a number of advancements in the areas of contraception, HIV prevention and a combination of the two.   CONRAD's original mission focused solely on developing new methods of contraception for men and women in the developing world.  With the advent of the HIV/AIDS epidemic, Dr. Gabelnick worked to form public and private partnerships to fund and develop methods of HIV prevention.  The program continued to also research non-hormonal methods of contraception for women and hormonal contraceptives for men. 

"As I look ahead to the challenges that lay before us in the field, I'm happy to say that we have the best team in place to meet those challenges.  Gustavo, along with Doug Colvard, Jill Schwartz, Marianne Callahan and the excellent staff that we have will continue to do an amazing job, and I look forward to working in an advisory capacity to support our important work," said Dr. Gabelnick. 

Dr. Gabelnick earned his undergraduate and master’s degrees at the Massachusetts Institute of Technology and a PhD at Princeton. Prior to establishing CONRAD, he spent 18 years with the National Institutes of Health.  Dr. Gabelnick has served on panels of the National Research Council, National Institutes of Health and the World Health Organization and is a past President of the Society for the Advancement of Reproductive Care.

Dr. Gabelnick has been recognized by the International Conference on AIDS in India for a lifetime devoted to reproductive health and in 2010 received the Lifetime Achievement Award at the International Microbicides Conference. In 1997, EVMS presented Dr. Gabelnick with the President’s Medallion for Distinguished Service in recognition of his contributions to EVMS and to the advancement of science.

Dr. Doncel joined the EVMS Department of Obstetrics and Gynecology in 1990, where he is currently a Professor. With his pioneering work on microbicides and sperm function inhibitors, Dr. Doncel laid the foundation for CONRAD’s expansion into HIV and multipurpose prevention technologies. He is an accomplished researcher with skills that span basic and clinical science. Dr. Doncel currently is the principal and co-principal investigator of grants totaling more than $138 million.

He is a reviewer for the U.S. National Institutes of Health and the European Commission Directorate General for Research and Innovation, and an expert advisor to the World Health Organization.  He is also a member of scientific advisory boards of several national and international research organizations. Dr. Doncel received the Dean’s Faculty Achievement Award from EVMS in 2009 and is the author of more than 100 peer-reviewed scientific publications and several U.S. and international patents on antimicrobial contraceptives and microbicides.

"It is a great honor to serve as the next Executive Director of CONRAD and I will strive to emulate Henry's achievements and dedication to the program. CONRAD has extensive expertise in reproductive health R&D and a team of highly qualified individuals. Together we will continue developing innovative prevention technologies designed to improve women's health, especially in resource-constrained countries," said Dr. Doncel.